tirzepatide gpl1 (GLP-1 / GIP) Molecular structure of tirzepatide and

Alatassi and her team

H., Smith, L

Clinical studies show 20% to 30% improvement in skin firmness after twelve weeks of topical use

Purchasing from unauthorized sources, including international online pharmacies, social media sellers, or unlicensed websites, poses serious health risks including counterfeit products, improper storage, and lack of medical oversight

For autoimmune patients who independently qualify for tirzepatide treatment based on metabolic criteria, the potential anti-inflammatory properties represent a reason to consider tirzepatide favorably among available GLP-1/GIP medication options

Int Arch Allergy Immunol 162(1):2538